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Abstract 
We report a case of central serous chorioretinopathy after rhinoplasty for deviation of 
the nasal septum in a 23-year-old Caucasian man. The patient complained of 
deterioration of vision in the right eye 4 days after rhinoplasty. At presentation, visual 
acuity of the right eye was 6/9 with metamorphopsia. Fluorescein angiography revealed 
a focal retinal pigment epithelium leakage and optical coherence tomography an 
increase in macular thickness to 245 μm. The left eye was normal. One month after the 
operation, without any treatment, visual acuity returned to 6/6, the leakage of the retinal 
pigment epithelium disappeared and the macular thickness returned to 183 μm. To the 
best of our knowledge, central serous chorioretinopathy after rhinoplasty has not been 
previously reported. This case report shows a possible association between the 
postoperative stress and central serous chorioretinopathy. Moreover, it widens the 
spectrum of drugs associated with the occurrence of the disease. 
 
Introduction 
Central serous chorioretinopathy (CSCR) is a chronic idiopathic condition affecting 
young to middle-aged patients with men affected more commonly than women. It is 
characterized by serous detachment of the neurosensory retina, with focal or multifocal 
areas of leakage of the retinal pigment epithelium (RPE) affecting the macular area. The 
exact cause of CSCR is not clearly understood. Nevertheless, it is associated with 
psychological stress and systemic corticosteroid therapy, which causes hyperpermeability 
of choriocapillaries, leading to dysfunctional degeneration of the RPE [1, 2].  
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Case Report 
A 23-year-old man presented with a sudden decrease of visual acuity of the right eye (RE) 4 days 
after rhinoplasty for a deviation of the nasal septum. General anesthesia was induced with propofol 2–5 
mg/kg i.v. and sufentanil 0.5 μg/kg i.v. For the first 2 postoperative days, xylometazoline drops were 
applied topically. No corticosteroids, antibiotics or other postoperative treatment was used. At 
presentation, best-corrected visual acuity of the RE was 6/9 with metamorphopsia. Fundus examination 
revealed a well-delineated serous elevation of the macula and fluorescein angiography (FA) showed a 
focal RPE leakage. The optical coherence tomography (OCT) sections through the macula depicted a 
mild neurosensory retinal detachment with an increase in retinal thickness equal to 245 μm (fig. 1). The 
left eye was normal. Two weeks later, without any treatment, a gradual improvement of the symptoms 
was assessed. One month after the operation, visual acuity of the RE returned to 6/6 and the 
neurosensory retinal detachment disappeared. Also, FA revealed the disappearance of RPE leakage and 
the retinal thickness of the macula measured with OCT was 183 μm (fig. 2). 
Discussion 
CSCR is a multifactorial disease with controversial etiopathology and it is usually 
associated with steroid use, pregnancy and stress. The exact mechanism by which 
glucocorticoids are involved in the development of CSCR is still unknown. It is possible 
that a constitutionally determined susceptibility of the posterior blood-retinal barrier 
must be present so that, under the effect of exogenous or endogenous glucocorticoids, 
CSCR develops [3]. Nevertheless, Kapetanios et al. [4] found elevated values of urinary 
free cortisol in patients suffering from CSCR not exposed to exogenous glucocorticoids 
and without biological signs of endogenous Cushing’s syndrome. Psychologic stress has 
been known to produce hypothalamic-pituitary-adrenal axis abnormalities like 
endogenous cortical excess, which has been found in some patients with CSCR [5]. 
Additionally, some psychopharmacologic and other medications may be risk factors. In 
fact, the use of imidazole derivatives like oxy- and xylometazoline, which directly 
stimulate alpha-receptors and are more alpha-2-selective, are associated with the 
manifestation of CSCR [6, 7]. 
In our case, the use of xylometazoline may have enhanced the post-traumatic stress 
and induced adrenergic stimulation leading to an increase in the choroidal circulation 
and alteration of the pump action of the RPE, which is related with the development of 
the CSCR. The disappearance of the macular edema after the discontinuation of 
xylometazoline supports this hypothesis. Contrary to this hypothesis, Riva et al. [8] state 
that adrenergic stimulation surely increases blood pressure. However, the simultaneous 
increase in choroidal resistance has no effect on choroidal blood flow, which will be 
regulated to be maintained constant. 
In summary, we present a case of CSCR after rhinoplasty, which to the best of our 
knowledge has not been previously reported. This case shows a possible association 
between the postoperative stress or the use of xylometazoline and CSCR and widens the 
spectrum of drugs associated with the occurrence of the disease. 
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Fig. 1. At presentation, FA showed a leakage of the RPE within the macular avascular zone in the RE 
(a). OCT sections through the macula depict an increase in retinal thickness (b). 
 
  
Case Rep Ophthalmol 2010;1:90–93 
DOI: 10.1159/000322235 
Published online: 
November 6, 2010 
© 2010 S. Karger AG, Basel 
ISSN 1663–2699 
www.karger.com/cop 
 
 
93
 
Fig. 2. One month after rhinoplasty, the leakage of the RPE in the RE disappeared (a). OCT sections 
through the macula depict a decrease in retinal thickness (b). 
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